Patient Blood Management Market Size, Share, Trends, Growth Outlook

Patient Blood Management Market is estimated to increase at a Compounded Annual Growth Rate of 6.9% CAGR over the forecast period from 2024 to 2030

The Patient Blood Management Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Instruments, Accessories, Software), By End-User (Blood Banks, Hospitals, Diagnostic Clinics, Pathology Labs, Others).

An Introduction to Patient Blood Management Market in 2024

Patient blood management (PBM) is a comprehensive, evidence-based approach to managing patients' blood health before, during, and after medical procedures to optimize patient outcomes and minimize the need for blood transfusions. In 2024, the market for patient blood management continues to grow, driven by increasing awareness of the risks associated with blood transfusions, rising healthcare costs, and the emphasis on patient safety and quality of care. Patient blood management encompasses strategies such as preoperative anemia management, intraoperative blood conservation techniques, and postoperative hemostasis optimization, which aim to reduce the need for blood transfusions, improve patient outcomes, and enhance resource utilization in healthcare settings. These strategies include iron supplementation, erythropoiesis-stimulating agents, cell salvage systems, minimally invasive surgical techniques, and point-of-care coagulation monitoring devices, among others. By implementing PBM programs, healthcare providers can reduce the risks of transfusion-related complications, such as infections, transfusion reactions, and immunologic complications, while improving patient recovery times, reducing hospital length of stay, and lowering healthcare costs. With advancements in hematology diagnostics, blood management algorithms, and interdisciplinary collaboration among healthcare teams, PBM offers a holistic and patient-centered approach to blood health that benefits patients across a wide range of medical specialties and clinical settings. As healthcare systems strive to deliver high-quality care while optimizing resource utilization, patient blood management emerges as a critical component of comprehensive patient care pathways that prioritize patient safety, improve clinical outcomes, and enhance the overall patient experience.

Market Trend: Shift Towards Value-Based Healthcare Models

A significant market trend in patient blood management is the shift towards value-based healthcare models, emphasizing cost-effective strategies that optimize patient outcomes and resource utilization throughout the continuum of care. With healthcare systems worldwide facing financial constraints and increasing scrutiny on healthcare expenditures, there's a growing imperative to reduce unnecessary blood transfusions, mitigate transfusion-related complications, and improve patient safety and clinical outcomes. Patient blood management programs, focusing on evidence-based practices such as preoperative optimization, intraoperative blood conservation, and rational transfusion practices, are gaining traction as integral components of value-based care initiatives, driving the adoption of holistic approaches that prioritize patient-centered outcomes and healthcare sustainability.

Market Driver: Growing Awareness of Transfusion Risks and Blood Conservation Strategies

A primary driver fueling the growth of the patient blood management market is the growing awareness among healthcare providers and policymakers of the risks associated with blood transfusions and the need for proactive blood conservation strategies to minimize transfusion-related complications and improve patient outcomes. With mounting evidence linking transfusion with adverse outcomes such as infections, immunomodulation, and transfusion reactions, there's a heightened focus on implementing measures to reduce unnecessary transfusions and optimize hemostasis and tissue perfusion through alternative interventions. Moreover, the recognition of patient blood management as a multidisciplinary approach involving clinicians, transfusion specialists, and quality improvement teams drives investments in education, training, and quality improvement initiatives aimed at fostering a culture of blood stewardship and patient safety across healthcare institutions.

Market Opportunity: Integration of Digital Health Technologies and Decision Support Tools

An enticing opportunity within the patient blood management market lies in the integration of digital health technologies and decision support tools to enhance clinical decision-making, optimize transfusion practices, and improve patient outcomes. By leveraging electronic health records, clinical decision support systems, and predictive analytics, stakeholders can identify patients at risk of transfusion complications, tailor blood management strategies based on individual patient characteristics, and track transfusion outcomes in real time. Furthermore, the development of mobile applications and telemedicine platforms enables remote monitoring and consultation, facilitating timely interventions and continuity of care. Collaborations between healthcare providers, technology vendors, and regulatory agencies can drive innovation in digital patient blood management solutions, empowering clinicians with actionable insights and facilitating data-driven improvements in transfusion practices and patient outcomes.

Patient Blood Management Market Share Analysis: Blood Processing Devices is the fastest growing segment over the forecast period to 2030

Among the various segments in the Patient Blood Management Market, blood processing devices emerge as the fastest-growing segment. This growth can be attributed to several factors. Blood processing devices play a crucial role in patient blood management by facilitating the separation of blood components, such as red blood cells, platelets, and plasma, to meet specific patient needs during transfusion therapy. The increasing demand for blood components due to rising surgical procedures, trauma cases, and chronic diseases drives the adoption of blood processing devices in hospitals, blood banks, diagnostic clinics, and pathology labs. Moreover, advancements in blood processing technology, such as automation, improved efficiency, and reduced processing times, enhance the overall workflow and patient outcomes. Additionally, stringent regulatory standards emphasizing the safety and quality of blood products further boost the adoption of blood processing devices in healthcare settings.

Patient Blood Management Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAsahi Kasei Corp, B. Braun SE, bioMérieux SA, Grifols S.A., Haemonetics Corp, Haier Biomedical (Qingdao) Co. Ltd, Immucor Inc, LivaNova PLC, Macopharma SA, Terumo Corp

Patient Blood Management Market Segmentation

By Product
Instruments
-Blood Processing Devices
-Blood Transfusion Devices
-Blood Culture Screening Devices
-Diagnostic and Testing Instruments
Blood Storage Devices
Accessories
-Syringes and Needles
-Vials and Tubes
-Blood Bags
Others
Reagents and Kits
-Blood Culture Media
-Blood Typing Reagents
-Slide Staining Reagents
-Assay Kits
Software
By End-User
Blood Banks
Hospitals
Diagnostic Clinics
Pathology Labs
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Patient Blood Management Market Companies

Asahi Kasei Corp
B. Braun SE
bioMérieux SA
Grifols S.A.
Haemonetics Corp
Haier Biomedical (Qingdao) Co. Ltd
Immucor Inc
LivaNova PLC
Macopharma SA
Terumo Corp

Reasons to Buy the Patient Blood Management Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Patient Blood Management Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Patient Blood Management Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Patient Blood Management Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Patient Blood Management Market Size Outlook, $ Million, 2021 to 2030
3.2 Patient Blood Management Market Outlook by Type, $ Million, 2021 to 2030
3.3 Patient Blood Management Market Outlook by Product, $ Million, 2021 to 2030
3.4 Patient Blood Management Market Outlook by Application, $ Million, 2021 to 2030
3.5 Patient Blood Management Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Patient Blood Management Industry
4.2 Key Market Trends in Patient Blood Management Industry
4.3 Potential Opportunities in Patient Blood Management Industry
4.4 Key Challenges in Patient Blood Management Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Patient Blood Management Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Patient Blood Management Market Outlook by Segments
7.1 Patient Blood Management Market Outlook by Segments, $ Million, 2021- 2030
By Product
Instruments
-Blood Processing Devices
-Blood Transfusion Devices
-Blood Culture Screening Devices
-Diagnostic and Testing Instruments
Blood Storage Devices
Accessories
-Syringes and Needles
-Vials and Tubes
-Blood Bags
Others
Reagents and Kits
-Blood Culture Media
-Blood Typing Reagents
-Slide Staining Reagents
-Assay Kits
Software
By End-User
Blood Banks
Hospitals
Diagnostic Clinics
Pathology Labs
Others

8 North America Patient Blood Management Market Analysis and Outlook To 2030
8.1 Introduction to North America Patient Blood Management Markets in 2024
8.2 North America Patient Blood Management Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Patient Blood Management Market size Outlook by Segments, 2021-2030
By Product
Instruments
-Blood Processing Devices
-Blood Transfusion Devices
-Blood Culture Screening Devices
-Diagnostic and Testing Instruments
Blood Storage Devices
Accessories
-Syringes and Needles
-Vials and Tubes
-Blood Bags
Others
Reagents and Kits
-Blood Culture Media
-Blood Typing Reagents
-Slide Staining Reagents
-Assay Kits
Software
By End-User
Blood Banks
Hospitals
Diagnostic Clinics
Pathology Labs
Others

9 Europe Patient Blood Management Market Analysis and Outlook To 2030
9.1 Introduction to Europe Patient Blood Management Markets in 2024
9.2 Europe Patient Blood Management Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Patient Blood Management Market Size Outlook by Segments, 2021-2030
By Product
Instruments
-Blood Processing Devices
-Blood Transfusion Devices
-Blood Culture Screening Devices
-Diagnostic and Testing Instruments
Blood Storage Devices
Accessories
-Syringes and Needles
-Vials and Tubes
-Blood Bags
Others
Reagents and Kits
-Blood Culture Media
-Blood Typing Reagents
-Slide Staining Reagents
-Assay Kits
Software
By End-User
Blood Banks
Hospitals
Diagnostic Clinics
Pathology Labs
Others

10 Asia Pacific Patient Blood Management Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Patient Blood Management Markets in 2024
10.2 Asia Pacific Patient Blood Management Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Patient Blood Management Market size Outlook by Segments, 2021-2030
By Product
Instruments
-Blood Processing Devices
-Blood Transfusion Devices
-Blood Culture Screening Devices
-Diagnostic and Testing Instruments
Blood Storage Devices
Accessories
-Syringes and Needles
-Vials and Tubes
-Blood Bags
Others
Reagents and Kits
-Blood Culture Media
-Blood Typing Reagents
-Slide Staining Reagents
-Assay Kits
Software
By End-User
Blood Banks
Hospitals
Diagnostic Clinics
Pathology Labs
Others

11 South America Patient Blood Management Market Analysis and Outlook To 2030
11.1 Introduction to South America Patient Blood Management Markets in 2024
11.2 South America Patient Blood Management Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Patient Blood Management Market size Outlook by Segments, 2021-2030
By Product
Instruments
-Blood Processing Devices
-Blood Transfusion Devices
-Blood Culture Screening Devices
-Diagnostic and Testing Instruments
Blood Storage Devices
Accessories
-Syringes and Needles
-Vials and Tubes
-Blood Bags
Others
Reagents and Kits
-Blood Culture Media
-Blood Typing Reagents
-Slide Staining Reagents
-Assay Kits
Software
By End-User
Blood Banks
Hospitals
Diagnostic Clinics
Pathology Labs
Others
12 Middle East and Africa Patient Blood Management Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Patient Blood Management Markets in 2024
12.2 Middle East and Africa Patient Blood Management Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Patient Blood Management Market size Outlook by Segments, 2021-2030
By Product
Instruments
-Blood Processing Devices
-Blood Transfusion Devices
-Blood Culture Screening Devices
-Diagnostic and Testing Instruments
Blood Storage Devices
Accessories
-Syringes and Needles
-Vials and Tubes
-Blood Bags
Others
Reagents and Kits
-Blood Culture Media
-Blood Typing Reagents
-Slide Staining Reagents
-Assay Kits
Software
By End-User
Blood Banks
Hospitals
Diagnostic Clinics
Pathology Labs
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Asahi Kasei Corp
B. Braun SE
bioMérieux SA
Grifols S.A.
Haemonetics Corp
Haier Biomedical (Qingdao) Co. Ltd
Immucor Inc
LivaNova PLC
Macopharma SA
Terumo Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Instruments
-Blood Processing Devices
-Blood Transfusion Devices
-Blood Culture Screening Devices
-Diagnostic and Testing Instruments
Blood Storage Devices
Accessories
-Syringes and Needles
-Vials and Tubes
-Blood Bags
Others
Reagents and Kits
-Blood Culture Media
-Blood Typing Reagents
-Slide Staining Reagents
-Assay Kits
Software
By End-User
Blood Banks
Hospitals
Diagnostic Clinics
Pathology Labs
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)